| 1 day | +3.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 31/12/2024 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 31/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 03/03/2020 |
| Director/Board Member | 45 | 03/03/2020 | |
Axel Rebien
BRD | Director/Board Member | 55 | 31/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/25 | Sell | Chairman | 1,315 | 0.0110% | ||
| 11/08/25 | Sell | Chairman | 39,678 | 0.3306% | ||
| 08/08/25 | Sell | Chairman | 873 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.13% | +3.13% | - | - | 447M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.67% | +2.17% | +37.02% | +69.16% | 444.85B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
Employees
98
Sector
Pharmaceuticals
